Adverse effects of inhaled budesonide (800 μg) on growth and collagen turnover in children with asthma: A double-blind comparison of once-daily versus twice-daily administration

Journal of Pediatrics

Volumn 133, Issue 5, 1998, Pages 608-612

  Heuck, C ^a   Wolthers, O D ^a   Kollerup, G ^a   Hansen, M ^a   Teisner, B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; COLLAGEN; DEOXYPYRIDINOLINE; PROCOLLAGEN; PYRIDINOLINE;

ARTICLE; ASTHMA; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; COLLAGEN METABOLISM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GROWTH RETARDATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LEG LENGTH; MALE; PRIORITY JOURNAL; STEROID THERAPY;

EID: 0031798282     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(98)70098-8     Document Type: Article

References (42)

1. PJ Barnes Inhaled glucocorticoids for asthma N Engl J Med 332 1995 868 875
2. OD Wolthers Long, intermediate and short term growth studies in asthmatic children treated with inhaled glucocorticosteroids Eur Res J 9 1996 821 829
3. JF Price Corticosteroids and other anti-inflammatory agents in the treatment of children Eur Respir Rev 4 1994 27 32
4. OD Wolthers S Pedersen Short term linear growth in asthmatic children during treatment with prednisolone BMJ 301 1990 145 148
5. OD Wolthers S Pedersen Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids Pediatrics 89 1992 839 842
6. OD Wolthers S Pedersen Growth of asthmatic children during treatment with budesonide: a double blind trial BMJ 303 1991 163 165
7. OD Wolthers A Juul M Hansen J Müller S Pedersen The insulin-like growth factor axis and collagen turnover in asthmatic children treated with inhaled budesonide Acta Paediatr Scand 84 1995 393 397
8. C Heuck OD Wolthers M Hansen G Kollerup Short-term growth and collagen turnover in asthmatic adolescents treated with the inhaled glucocorticoid budesonide Steroids 62 1997 659 664
9. L Balfour-Lynn Growth and childhood asthma Arch Dis Child 61 1986 1049 1055
10. JG Harter JR Reddy GW Thorn Studies on an intermittent corticosteroid dosage regimen N Engl J Med 269 1963 591 596
11. MA Byron J Jackson BM Ansell Effect of different corticosteroid regimens on hypothalamic-pituitary-adrenal axis and growth in juvenile chronic arthritis J R Soc Med 76 1983 452 457
12. C Heuck T Ternowitz T Herlin OD Wolthers Short term growth effects of topical glucocorticosteroids in children with atopic dermatitis Pediatr Dermatol 15 1998 7 11
13. JM Tanner The development of the reproductive system Growth at adolescence 1962 : Blackwell Scientific Publications Oxford 28 39
14. IM Valk AM Chabloz AG Smals PW Kloppenborg FG Cassorla EA Schutte Accurate measurements of the lower leg length and the ulnar length and its application in short term growth measurement Growth 47 1983 53 66
15. L Risteli Assay of collagen metabolism 1993 : Kirjapapainu Libris Oy Helsinki
16. J Risteli I Elomaa S Niemi A Novamo L Risteli Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation Clin Chem 39 1993 635 640
17. O Ørum M Hansen CH Jensen HA Sørensen LB Jensen K Hørslev Petersen Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidism Bone 19 1996 157 163
18. NT Hertel M Stoltenberg A Juul KM Main J Müller CT Nielsen Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate J Clin Endocrinol Metab 76 1993 924 927
19. G Kollerup G Thamsborg H Bhatia OH Sørensen Quantitation of urinary hydroxypyridinium cross-links from collagen by high-performance liquid chromatography Scand J Clin Lab Invest 52 1992 657 662
20. M Hills P Armitage The two-period cross-over clinical trial Br J Clin Pharmacol 8 1979 7 20
21. OD Wolthers K Konstantin-Hansen S Pedersen KE Petersen Knemometry in the assessment of short-term linear growth in a population of healthy school children Horm Res 37 1992 156 159
22. T Nicholas CA Nugent FH Tyler Diurnal variation in suppression of adrenal function by glucocorticoids J Clin Endocrinol 25 1965 343 349
23. SD Grant PH Forsham VC DiRaimondo Suppression of 17-hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinolone N Engl J Med 273 1965 1115 1118
24. A Reinberg P Guillet P Gervais J Ghata D Vignaud C Abulker One month chronocorticotherapy (Dutimelan 8-15 mite). Control of the asthmatic condition without adrenal suppression and circadian rhythm alteration Chronobiologia 4 1977 295 312
25. A Reinberg P Gervais M Chaussade G Fraboulet B Duburque Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma J Allergy Clin Immunol 71 1983 425 433
26. WM Hunter WM Rigal The diurnal pattern of plasma growth hormone concentration in children and adolescents J Endocrinol 34 1966 147 153
27. A Ryrfeldt P Andersson S Edsbacker M Tonnesson D Davies R Pauwels Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid Eur J Respir Dis 122 1982 86 95
28. DG Tinkelman CE Reed HS Nelson KP Offord Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children Pediatrics 92 1993 64 77
29. S Pedersen G Steffensen SV Ohlsson The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler Br J Clin Pharmacol 36 1993 211 214
30. NH Birkebæk G Esberg K Andersen OD Wolthers C Hassager Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate Arch Dis Child 73 1995 524 527
31. J Risteli S Niemi P Trivedi O Maentausta AP Mowat L Risteli Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen Clin Chem 34 1988 715 718
32. AM Parfitt LS Simon AR Villanueva SM Krane Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase J Bone Miner Res 2 1987 427 436
33. JD Delmas A Schlemmer E Gineyts B Riis C Christiansen Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis J Bone Miner Res 6 1991 639 644
34. OD Wolthers A Juul M Hansen J Müller S Pedersen The insulin-like growth factor axis and collagen turnover during prednisolone treatment Arch Dis Child 71 1994 409 413
35. R Sorva M Turpeinen BK Juntunen SL Karonen A Sorva Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma J Allergy Clin Immunol 90 1992 808 815
36. H Puolijoki J Risteli J Herrala L Risteli K Liippo Effect of inhaled beclomethasone on serum markers of collagen metabolism in postmenopausal asthmatic women Respir Med 90 1996 339 342
37. PR Ebeling JM Peterson BL Riggs Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases J Bone Miner Res 7 1992 1243 1250
38. SG Linkhart TA Linkhart AK Taylor JE Wergedal P Bettica DJ Baylink Synthetic peptide-based immunoassay for amino-terminal propeptide of type I procollagen: application for evaluation of bone formation Clin Chem 39 1993 2254 2258
39. P Trivedi J Risteli L Risteli PC Hindmarsh CG Brook AP Mowat Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders Pediatr Res 30 1991 276 280
40. OD Wolthers M Hansen A Juul HK Nielsen S Pedersen Urine cortisol excretion, knemometry and measures of the insulin-like growth factor axis and collagen turnover in the assessment of systemic activity of inhaled glucocorticosteroids in children Pediatr Res 41 1997 44 50
41. C Möller L Strömsberg G Oldæus E Arweström M Kjellmann Administration of budesonide via Turbuhaler (200 μg and 400 μg) once daily is as effective as when given twice daily in children with asthma [abstract] Eur Respir J 9 suppl 239 1996 115s
42. AH Jones CG Langdon PS Lee SA Lingham JP Nankani RM Follows Pulmicort Turbuhaler once daily as initial prophylactic therapy for asthma Respir Med 88 1994 293 299